5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the Food and Drug Administration in the past week.

1. Merck's HIV drug Isentress is now available as a higher-dose, once-daily formula.

2. Rebinyn is intended to treat adults and children with hemophilia B, an inherited blood disorder that causes prolonged or spontaneous bleeding.

3. Atomoxetine is a generic version of Eli Lilly's attention-deficit/hyperactivity disorder drug, Strattera.

4. Zykadia may now be used as a first-line treatment for patients with metastatic non-small cell lung cancer whose tumors carry a specific enzyme identified through an FDA-approved test.

5. Nebivolol represents the first generic version of the hypertension drug Bystolic.

More articles on supply chain:

FDA OKs higher dose of Merck's HIV drug
DHL exec: 3 tech solutions innovating healthcare supply chain
Exact Sciences stock jumps 12% after UnitedHealth issues positive coverage for Cologuard

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers